BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach.
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach. The company was founded in 2016 and is headquartered in Jerusalem, Yerushalayim, Israel.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 16, 2021 | Series Unknown | $40M | 1 | — | — | Detail |
May 15, 2018 | Series Unknown | $8.80M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
OurCrowd | — | Series Unknown |